IRIS
DAGNA, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.452
NA - Nord America 1.801
AS - Asia 1.103
AF - Africa 25
OC - Oceania 22
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.779
SE - Svezia 1.083
IT - Italia 627
CN - Cina 520
SG - Singapore 393
RU - Federazione Russa 346
FI - Finlandia 106
DE - Germania 87
IN - India 62
IE - Irlanda 47
GB - Regno Unito 44
PH - Filippine 23
NL - Olanda 22
CA - Canada 18
HK - Hong Kong 18
TR - Turchia 16
AU - Australia 15
FR - Francia 13
IR - Iran 12
JP - Giappone 12
UA - Ucraina 12
NO - Norvegia 11
IL - Israele 10
ES - Italia 9
MA - Marocco 9
PK - Pakistan 9
AT - Austria 7
BE - Belgio 7
NZ - Nuova Zelanda 7
ZA - Sudafrica 7
BR - Brasile 6
EU - Europa 5
MY - Malesia 5
DK - Danimarca 4
KR - Corea 4
MK - Macedonia 4
MX - Messico 4
PT - Portogallo 4
SA - Arabia Saudita 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GR - Grecia 3
MO - Macao, regione amministrativa speciale della Cina 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
DZ - Algeria 2
ID - Indonesia 2
LB - Libano 2
PE - Perù 2
PL - Polonia 2
QA - Qatar 2
RO - Romania 2
TG - Togo 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
BD - Bangladesh 1
IQ - Iraq 1
KZ - Kazakistan 1
ME - Montenegro 1
SI - Slovenia 1
VN - Vietnam 1
Totale 5.418
Salva come PNG Salva come JPEG
Città #
Lawrence 278
Princeton 278
Shanghai 269
Singapore 221
New York 209
Ashburn 203
Moscow 170
Milan 152
Boardman 121
Helsinki 95
Rome 54
Dublin 42
Dallas 37
Pune 37
Seattle 36
Los Angeles 32
Washington 30
Ancona 22
Guangzhou 20
Florence 15
Vaprio d'Adda 15
Hong Kong 14
Rotterdam 13
London 12
Beijing 11
Shenzhen 11
Lappeenranta 10
Turin 10
Bologna 9
Jiaxing 9
Makati City 9
Genoa 8
Pisa 8
Bergamo 7
Cagliari 7
Cape Town 7
Galliate 7
Istanbul 7
Oslo 7
Ankara 6
Hanover 6
Lahore 6
Manchester 6
Melbourne 6
Padova 6
Redwood City 6
Taizhou 6
Auckland 5
Brussels 5
Khemisset 5
Mountain View 5
Osimo 5
Pamplona 5
Quezon City 5
Saint Louis 5
Santa Clara 5
Toronto 5
Verona 5
Vittoria 5
Xi'an 5
Atlanta 4
Borås 4
Brisbane 4
Catania 4
Dalmine 4
Falkenstein 4
Gatchina 4
Goito 4
Hyderabad 4
Indianapolis 4
Mestrino 4
Minerbio 4
Munich 4
Nantong 4
Nellore 4
Perugia 4
Quanzhou 4
Seoul 4
St Petersburg 4
Trondheim 4
York 4
Acate 3
Amadora 3
Angera 3
Athens 3
Ballincollig 3
Cabanatuan City 3
Casablanca 3
City of Westminster 3
Clifton 3
Falconara Marittima 3
Foshan 3
Frankfurt am Main 3
Gallarate 3
George Town 3
Jeddah 3
Kyiv 3
Lehnice 3
Melzo 3
Mumbai 3
Totale 2.756
Salva come PNG Salva come JPEG
Nome #
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 156
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 55
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 47
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 46
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 43
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 41
Prone positioning in awake COVID-19 patients: a systematic review and meta-analysis 37
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 37
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 37
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 36
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 36
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 35
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 34
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 33
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 33
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 33
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al ' by Cheng and Zhang 33
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 32
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 32
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 32
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 32
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 31
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 31
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 31
Anti-TNF alpha agents in Takayasu's arteritis: An Italian experience 30
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 30
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 30
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 30
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 30
Biobanking for COVID-19 research 29
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients 28
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database 27
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Testosterone in males with COVID-19: A twelve-month cohort study 27
Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis 27
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 27
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 27
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 27
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 26
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 26
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis 26
Obesity and its role in the management of rheumatoid and psoriatic arthritis 26
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 26
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 26
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 25
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 25
Systemic lupus erythematosus and COVID-19: what we know so far 25
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 25
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 25
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 25
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 24
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 24
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 24
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 24
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 24
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 24
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 24
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 24
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 24
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 23
C3-glomerulopathy and MGUS: The skin beyond the kidney 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 23
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? (Journal of Neuroimmune Pharmacology, (2021), 16, 1, (1-3), 10.1007/s11481-020-09966-z) 23
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial 22
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 22
A Novel Histiocytosis With Synovial and Skin Involvement 22
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 22
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 22
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 22
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 22
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? 22
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 22
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series 21
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 21
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 21
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 21
Anakinra for patients with COVID-19 – Authors' reply 21
Therapeutic strategies for virus-negative myocarditis: a comprehensive review 21
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 21
Drug retention rates of biological agents in adult onset Still's disease 21
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 20
Urgent manifestations of immunoglobulin G4-related disease 20
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 20
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias 20
Clinically isolated aortitis successfully treated with methotrexate monotherapy 20
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 20
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia 19
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 19
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis 19
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 19
Advances in potential targeted therapies for Erdheim-Chester disease 19
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 19
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 19
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 19
Cardiac immune-related adverse events: an immune-cardio-oncology puzzle 19
A virus-free cellular model recapitulates several features of severe COVID-19 19
Totale 2.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 6 0 1 0 38 2
2020/2021119 6 0 13 8 1 27 31 6 6 4 13 4
2021/2022431 3 0 101 78 26 27 33 26 42 37 30 28
2022/20232.173 652 435 141 21 36 244 219 209 101 39 40 36
2023/20242.241 79 135 231 200 184 371 118 204 18 92 210 399
2024/20251.010 638 146 220 6 0 0 0 0 0 0 0 0
Totale 6.083